(Q46051781)

19 December 2017

title

Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study (English)

1 reference

19 December 2017

author

Giuseppe Novelli

6

1 reference

19 December 2017

Leonardo Palombi

7

1 reference

19 December 2017

Giuseppe Liotta

Giuseppe Liotta

9

0 references

Cinzia Ciccacci

Cinzia Ciccacci

1

0 references

Paola Borgiani

Paola Borgiani

8

0 references

Maria Cristina Marazzi

Maria C Marazzi

3

0 references

author name string

Davide Di Fusco

2

1 reference

19 December 2017

Ines Zimba

4

1 reference

19 December 2017

Fulvio Erba

5

1 reference

19 December 2017

language of work or name

1 reference

18 June 2013

1 reference

19 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

19 December 2017

volume

69

1 reference

19 December 2017

page(s)

1909-1916

1 reference

19 December 2017

issue

11

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-013-1549-x

exact match

0 references

cites work

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Human leukocyte antigens and drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Pharmacogenetics of HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1549-X

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry

21 January 2018

1 reference

12 December 2020

Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration

1 reference

12 December 2020

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

1 reference

12 December 2020

A marker for Stevens-Johnson syndrome ...: ethnicity matters

1 reference

12 December 2020

10.1007/S00228-013-1549-X

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

23774940

1 reference

19 December 2017